Long-term Clinical Efficacy and Safety Profile of Transurethral Resection of Prostate Versus Plasmakinetic Resection of the Prostate for Benign Prostatic Hyperplasia

Urology

Volumn 103, Issue , 2017, Pages 198-203

  Liu, Zhe ^a   Li, Yuan Wei ^a   Wu, Wan Rui ^a   Lu, Qiang ^a  

^a People's Hospital of Hunan   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM;

AGED; ARTICLE; BLADDER NECK STENOSIS; BLEEDING; BLOOD TRANSFUSION; CATHETERIZATION; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; DYSURIA; FLOW RATE; HEMATURIA; HUMAN; INCIDENCE; INCONTINENCE; INTERNATIONAL PROSTATE SYMPTOM SCORE; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OUTCOME ASSESSMENT; PATIENT SAFETY; PLASMAKINETIC RESECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE SURGERY; QUALITY OF LIFE; RESIDUAL URINE; RETROGRADE EJACULATION; SEXUAL FUNCTION; TRANSURETHRAL RESECTION; URETHRA STENOSIS; URINARY FREQUENCY; URINARY URGENCY; ARGON PLASMA COAGULATION; CHINA; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PROSTATE; PSYCHOLOGY; REOPERATION; RETROSPECTIVE STUDY; SEXUAL DYSFUNCTION; TREATMENT OUTCOME;

AGED; ARGON PLASMA COAGULATION; CHINA; COMPARATIVE EFFECTIVENESS RESEARCH; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; POSTOPERATIVE COMPLICATIONS; PROSTATE; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; REOPERATION; RETROSPECTIVE STUDIES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME;

EID: 85015327312     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2017.02.006     Document Type: Article

References (28)

1. 1 Speakman, M., Kirby, R., Doyle, S., et al. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH)—focus on the UK. BJU Int 115 (2015), 508–519.
2. 2 Djavan, B., Eckersberger, E., Finkelstein, J., et al. Benign prostatic hyperplasia: current clinical practice. Prim Care 37 (2010), 583–597.
3. 3 Leedahl, D.D., Vo, P.H., Maxson, P.M., et al. Benign prostatic hyperplasia: implications for pharmacologic treatment and perioperative care. J Pharm Pract 26 (2013), 52–58.
4. 4 Roehrborn, C.G., Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). Med Clin N Am 95 (2011), 87–100.
5. 5 Li, Z., Chen, P., Wang, J., et al. The impact of surgical treatments for lower urinary tract symptoms/benign prostatic hyperplasia on male erectile function: a systematic review and network meta-analysis. Medicine (Baltimore), 95, 2016, e3862.
6. 6 Hirik, E., Bozkurt, A., Karabakan, M., et al. Safety and efficacy of bipolar versus monopolar transurethral resection of the prostate: a comparative study. Urol J 12 (2015), 2452–2456.
7. 7 Lv, L., Wang, L., Fan, M., et al. Two-year outcome of high-risk benign prostate hyperplasia patients treated with transurethral prostate resection by plasmakinetic or conventional procedure. Urology 80 (2012), 389–394.
8. 8 Mamoulakis, C., Ubbink, D.T., de la Rosette, J.J., Bipolar versus monopolar transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. Eur Urol 56 (2009), 798–809.
9. 9 Skolarikos, A., Rassweiler, J., de la Rosette, J.J., et al. Safety and efficacy of bipolar versus monopolar transurethral resection of the prostate in patients with large prostates or severe lower urinary tract symptoms: post hoc analysis of a European multicenter randomized controlled trial. J Urol 195 (2016), 677–684.
10. 10 Liao, N., Yu, J., A study comparing plasmakinetic enucleation with bipolar plasmakinetic resection of the prostate for benign prostatic hyperplasia. J Endourol 26 (2012), 884–888.
11. 11 Zhao, Z., Zeng, G., Zhong, W., et al. A prospective, randomised trial comparing plasmakinetic enucleation to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: three-year follow-up results. Eur Urol 58 (2010), 752–758.
12. 12 Jefferys, A., Siassakos, D., Wardle, P., The management of retrograde ejaculation: a systematic review and update. Fertil Steril 97 (2012), 306–312.
13. 13 Kuntz, R.M., Lehrich, K., Ahyai, S., Does perioperative outcome of transurethral holmium laser enucleation of the prostate depend on prostate size?. J Endourol 18 (2004), 183–188.
14. 14 Zhang, F., Shao, Q., Herrmann, T.R., et al. Thulium laser versus holmium laser transurethral enucleation of the prostate: 18-month follow-up data of a single center. Urology 79 (2012), 869–874.
15. 15 Erturhan, S., Bayrak, Ö., Seçkiner, İ., et al. Comparative outcomes of plasmakinetic versus monopolar transurethral resection of benign prostatic hyperplasia: 7 years’ results. Turk J Urol 39 (2013), 220–225.
16. 16 Xie, C.Y., Zhu, G.B., Wang, X.H., et al. Five-year follow-up results of a randomized controlled trial comparing bipolar plasmakinetic and monopolar transurethral resection of the prostate. Yonsei Med J 53 (2012), 734–741.
17. 17 Mamoulakis, C., Skolarikos, A., Schulze, M., et al. Bipolar vs monopolar transurethral resection of the prostate: evaluation of the impact on overall sexual function in an international randomized controlled trial setting. BJU Int 112 (2013), 109–120.
18. 18 Zong, H.T., Peng, X.X., Yang, C.C., et al. The impact of transurethral procedures for benign prostate hyperplasia on male sexual function: a meta-analysis. J Androl 33 (2012), 427–434.
19. 19 Elshal, A.M., Elmansy, H.M., Elkoushy, M.A., et al. Male sexual function outcome after three laser prostate surgical techniques: a single center perspective. Urology 80 (2012), 1098–1104.
20. 20 Chung, A., Woo, H.H., Preservation of sexual function when relieving benign prostatic obstruction surgically: can a trade-off be considered?. Curr Opin Urol 26 (2016), 42–48.
21. 21 Pavone, C., Abbadessa, D., Scaduto, G., et al. Sexual dysfunctions after transurethral resection of the prostate (TURP): evidence from a retrospective study on 264 patients. Arch Ital Urol Androl 87 (2015), 8–13.
22. 22 Ahyai, S.A., Lehrich, K., Kuntz, R.M., Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur Urol 52 (2007), 1456–1463.
23. 23 Tang, Y., Li, J., Pu, C., et al. Bipolar transurethral resection versus monopolar transurethral resection for benign prostatic hypertrophy: a systematic review and meta-analysis. J Endourol 28 (2014), 1107–1114.
24. 24 Orihuela, E., Pow-Sang, M., Motamedi, M., et al. Mechanism of healing of the human prostatic urethra following thermal injury. Urology 48 (1996), 600–608.
25. 25 Maddox, M., Pareek, G., Al Ekish, S., et al. Histopathologic changes after bipolar resection of the prostate: depth of penetration of bipolar thermal injury. J Endourol 26 (2012), 1367–1371.
26. 26 McGowan-Smyth, S., Vasdev, N., Gowrie-Mohan, S., Spinal anesthesia facilitates the early recognition of TUR syndrome. Curr Urol 9 (2016), 57–61.
27. 27 Reich, O., Gratzke, C., Bachmann, A., et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 180 (2008), 246–249.
28. 28 Koca, O., Keleş, M.O., Kaya, C., et al. Plasmakinetic vaporization versus transurethral resection of the prostate: six-year results. Turk J Urol 40 (2014), 134–137.